<DOC>
	<DOCNO>NCT00038974</DOCNO>
	<brief_summary>This study design test hypothesis African-Americans respond less well combination pegylated interferon ribavirin therapy Caucasian-Americans chronic hepatitis C genotype 1 previously treat either interferon ribavirin . Reasons difference response , regardless race , study .</brief_summary>
	<brief_title>Hepatitis C Antiviral Resistance African-Americans</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Inclusion : Age 18 70 year screen Black/African American White/Caucasian Born United States Quantifiable Serum HCV RNA Hepatitis C genotype 1 Liver biopsy consistent chronic hepatitis C Negative urine pregnancy test Males Females must use two reliable form effective contraception drug followup . Exclusion : Previous treatment interferon ribavirin Positive test screen antiHIV Positive test HBsAg Alcohol consumption two drinks/day History chronic liver disease Pregnant breastfeed woman Male partner woman pregnant contemplate pregnancy Neutrophil count &lt; 1000 cells/mm3 Hgb &lt; 11 g/dl woman 12 g/dl men Platelet count &lt; 75,000 cells/mm3 . Thalassemia , spherocytosis , history GI bleeding increase risk anemia Serum creatinine level &gt; 1.5 time upper limit normal screen CrCl &lt; 75cc/min Current dialysis Alcohol drug abuse within 6 month Current ( &lt; 6 month ) severe psychiatric disorder History immunologically mediate disease Decompensated liver disease High risk cardiovascular/coronary artery disease Severe seizure disorder anticonvulsant use Solid organ bone marrow transplantation Thyroid disease poorly control prescribed medication History evidence retinopathy Chronic use oral steroid Inability unwillingness provide inform consent abide study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Interferon</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Viral load</keyword>
	<keyword>Genetics</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Immunology</keyword>
</DOC>